US Patent

US8389524 — Tricyclic nitrogen containing compounds as antibacterial agents

Method of Use · Assigned to Glaxo Group Ltd · Expires 2029-02-12 · 3y remaining

Vulnerability score 88/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects tricyclic nitrogen-containing compounds used as antibacterial agents.

USPTO Abstract

Tricyclic nitrogen containing compounds and their use as antibacterials. Z1 and Z2 are independently selected from CH and N.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-4166`	—

Patent Metadata

Patent number: US8389524
Jurisdiction: US
Classification: Method of Use
Expires: 2029-02-12
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Glaxo Group Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.